Wednesday, 16 October 2024
  
Login

Australia's most trusted
source of pharma news

Wednesday, 16 October 2024
News

Pfizer investor fight gets dirty

Posted 14 October 2024 PM

In a scathing letter, activist investor Starboard Value has accused Pfizer of coercing its former CEO and CFO into retracting a pledge to help Starboard turn the business around, pointing the finger at unnamed Pfizer employees or representatives and branding the alleged action as "flagrantly unethical and a significant breach of fiduciary obligations".

The frank letter to the Pfizer Board throws a shadow over a meeting between Starboard and CEO Albert Bourla and Pfizer's Lead Independent Director Shantanu Narayen scheduled for later this week. The main gripe of the activist investor is that it claims to have had former CEO Ian Read and ex-CFO Frank D'Amelio on board to help the company "pursue a better path forward" but now they've pulled out.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (17)

Clinical & Medical, R&D (17)

Regulatory, Pharmacovigilance & QA (7)

Other (14)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.